# Observational breast cancer studies recruiting: 601 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 601 trials that are observational for breast cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational breast cancer studies: 601 rows for $30.05, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 14 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/breast-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 601
- Recruiting or not yet: 601
- Read on: November 19, 2026

## Trials

The 25 newest of 601, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945548 | A Study Characterizing the Elevated Liver Enzymes in Ribociclib Treated HR+ HER2- Advanced Breast Cancer Patients Using a Machine Learning... | Novartis Pharmaceuticals | Observational | Not yet recruiting | Breast Cancer | 8,001 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945548) |
| November 17, 2026 | NCT07943494 | Multimodal LLM for Breast Cancer Radiotherapy Target Auto-Contouring and Planning | Sponsor not shown (see the record) | Observational | Not yet recruiting | Breast Cancer, Radiotherapy | 51,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943494) |
| November 4, 2026 | NCT07917117 | Improved Facial Skin Quality and Quality of Life After VYC-12L Treatment in Breast Cancer Survivors | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Observational | Recruiting | Quality of Life, Breast Neoplasms, Skin Aging, Hyaluronic Acid | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917117) |
| November 4, 2026 | NCT07916714 | Breast Cancer Real-World Insights and Decision Guidance Evaluation in Hong Kong | AstraZeneca | Observational | Not yet recruiting | Breast Neoplasms | 48,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916714) |
| November 4, 2026 | NCT07916337 | 3D Versus 2D Strain Echocardiography for Early Detection of Cardiotoxicity During Cancer Therapy | Region Skane | Observational | Recruiting | Cancer Related Cardiovascular Toxicity, Anthracycline Related Cardiotoxicity in Breast Cancer, Breast Cancer... | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916337) |
| October 27, 2026 | NCT07899463 | ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek Population | Hellenic Cooperative Oncology Group | Observational | Recruiting | ESR1 Gene Mutation, Breast Cancer (Locally Advanced or Metastatic), Hormon Receptor Positive Breast Cancer | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899463) |
| October 27, 2026 | NCT07899099 | Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Breast Cancer, Chemotherapy-induced Neutropenia | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899099) |
| October 27, 2026 | NCT07899047 | Albumin-Bound Paclitaxel (Ⅱ) in Patients With Advanced Breast Cancer | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Not yet recruiting | Breast Cancer, HER2-negative Breast Cancer, Advanced Breast Cancer | 1,372 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899047) |
| October 27, 2026 | NCT07896772 | Anti-Müllerian Hormone in Breast Cancer Clinical Practice | Masaryk Memorial Cancer Institute | Observational | Recruiting | Breast Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896772) |
| October 26, 2026 | NCT07894133 | Gait Parameters in Breast Cancer Receiving Chemotherapy Patients | Sponsor not shown (see the record) | Observational | Recruiting | Breast Cancer, Chemotherapy, Biodex Gait Trainer, Gait Parameters | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07894133) |
| October 22, 2026 | NCT07888881 | An Overview of Vaccination Coverage Among Patients Receiving Treatment for Breast Cancer at the ICO: Identifying Factors Associated With... | Institut Cancerologie de l'Ouest | Observational | Not yet recruiting | Breast Cancer | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888881) |
| October 20, 2026 | NCT07882147 | Diagnostic Accuracy and Utility of ZTE Added to Routine MRI | Sponsor not shown (see the record) | Observational | Not yet recruiting | Breast Cancer, MRI Imaging | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882147) |
| October 19, 2026 | NCT07881341 | Anatomy Impact on RT Breast Cancer | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Observational | Recruiting | Breast Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881341) |
| October 19, 2026 | NCT07880600 | Pre-Treatment Breast DCE-MRI AI Model to Predict Neoadjuvant Chemotherapy Benefit in Locally Advanced Triple-Negative Breast Cancer | Fujian Cancer Hospital | Observational | Recruiting | Breast Neoplasm Female, Triple -Negative Breast Cancer | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880600) |
| October 19, 2026 | NCT07880106 | Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast Cancer | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Observational | Recruiting | Lung Cancer Non-small Cell, Colorectal Cancer, Stomach Cancer, Hepatocellular Carcinoma, Breast Cancer | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880106) |
| October 19, 2026 | NCT07879937 | Artificial Intelligence Integration in Breast Cancer Screening: The ANIHTA Study | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Breast Neoplasms | 200,075 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879937) |
| October 16, 2026 | NCT07877376 | Impact of Cognitive Impairment on Chronic Pain in Breast Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Breast Cancer | 182 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877376) |
| October 9, 2026 | NCT07867925 | Predicting Endocrine Resistance Using Molecular Imaging and Liquid Biopsy in Metastatic Breast Cancer | Asan Medical Center | Observational | Not yet recruiting | Metastatic Breast Cancer (HR+/ HER2-) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867925) |
| October 9, 2026 | NCT07867470 | TROPION Breast Respond in 1L TNBC | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Observational | Not yet recruiting | Unresectable Triple-negative Breast Cancer, Metastatic Triple-negative Breast Cancer | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867470) |
| October 8, 2026 | NCT07865884 | Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy Specimens | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital | Observational | Not yet recruiting | Breast Cancer, Vascular Calcification, Coronary Artery Calcification, Atherosclerosis Cardiovascular Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865884) |
| October 6, 2026 | NCT07860866 | Blood Biomarkers for Breast Cancer Treatment Response | University of Pittsburgh | Observational | Not yet recruiting | Breast Cancer (Advanced/Metastatic), ER Positive | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860866) |
| October 2, 2026 | NCT07856225 | Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer | Fundación Santa Fe de Bogota | Observational | Recruiting | Breast Neoplasms, Triple Negative Breast Neoplasms, HER2-Positive Breast Cancer, Hormone Receptor-Positive Breast Cancer | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856225) |
| October 2, 2026 | NCT07855627 | Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements | M.D. Anderson Cancer Center | Observational | Recruiting | Lymphedema, Inflammatory Breast Cancer (IBC), Preoperative, Bioimpedance Measurement | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855627) |
| September 30, 2026 | NCT07850869 | A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced... | Sponsor not shown (see the record) | Observational | Recruiting | Breast Cancer (Locally Advanced or Metastatic) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850869) |
| September 29, 2026 | NCT07848061 | A Master Regulator of Lipid-Associated Macrophage Function in Cancer | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Breast Cancer, Head & Neck Cancer | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848061) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assiut University | 15 |
| Fudan University | 11 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 10 |
| M.D. Anderson Cancer Center | 9 |
| Memorial Sloan Kettering Cancer Center | 9 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 8 |
| Mayo Clinic | 8 |
| University Health Network, Toronto | 8 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 8 |
| Shengjing Hospital | 7 |
| Sunnybrook Health Sciences Centre | 7 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 7 |
| National Cancer Institute (NCI) | 7 |
| European Institute of Oncology | 7 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 6 |
| Assistance Publique - Hôpitaux de Paris | 6 |
| Istituti Clinici Scientifici Maugeri SpA | 6 |
| Vastra Gotaland Region | 6 |
| University of California, San Francisco | 5 |
| UNC Lineberger Comprehensive Cancer Center | 5 |
| Centro di Riferimento Oncologico - Aviano | 5 |
| Samsung Medical Center | 5 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 5 |
| Zhejiang Cancer Hospital | 4 |
| National Institute of Oncology, Hungary | 4 |

## By country

| Country | Trials |
| --- | --- |
| United States | 140 |
| China | 105 |
| Italy | 62 |
| France | 33 |
| Canada | 27 |
| United Kingdom | 20 |
| Germany | 19 |
| South Korea | 18 |
| Spain | 17 |
| Sweden | 13 |
| Netherlands | 13 |
| Egypt | 11 |
| Belgium | 10 |
| Turkey (Türkiye) | 8 |
| Greece | 7 |
| Austria | 7 |
| Taiwan | 6 |
| Switzerland | 6 |
| Denmark | 5 |
| Australia | 5 |
| Hungary | 5 |
| Ireland | 4 |
| Colombia | 4 |
| Singapore | 4 |
| Norway | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Blinds and shades companies in the United States](https://specstream.ai/data/businesses/blinds-and-shades-companies/united-states)
- [Occupational medicine clinics in the United States](https://specstream.ai/data/businesses/occupational-medicine-clinics/united-states)
- [Builders in the United States](https://specstream.ai/data/businesses/builders/united-states)
- [Orthotics providers in the United States](https://specstream.ai/data/businesses/orthotics-providers/united-states)
- [Cabinet makers in the United States](https://specstream.ai/data/businesses/cabinet-makers/united-states)
- [Patent law firms in the United States](https://specstream.ai/data/businesses/patent-law-firms/united-states)
